Categories Earnings, Health Care
Earnings Summary: Charles River Laboratories reports Q2 2023 results
Pharma company Charles River Laboratories International, Inc. (NYSE: CRL) on Wednesday reported financial results for the second quarter of 2023.
- For the quarter, the company reported revenues of $1.06 billion, up 8.9% from $973.1 million recorded in the prior-year quarter
- Net income attributable to common shareholders was $97.0 million in Q2, compared to $109.3 million for the same period in 2022
- On a per-share basis, Q2 unadjusted earnings decreased 11.3% year-over-year to $1.89 from $2.13 last year
- Adjusted profit was $138.3 million in the June quarter, which is down 2.5% from the prior-year period
- Earnings per share, on an adjusted basis, decreased 2.9% year-over-year to $2.69 during the three-month period
- The management expects revenues to increase in the range of 2.5% to 4.5% in fiscal 2023
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Earnings Preview: Microsoft expected to report higher Q3 revenue, profit
Tech behemoth Microsoft Corp. (NASDAQ: MSFT) is preparing to report its third-quarter 2025 results, amid expectations for a year-over-year increase in revenue and earnings. The company has performed well recently,
What to expect when eBay (EBAY) reports its Q1 2025 earnings results
Shares of eBay Inc. (NASDAQ: EBAY) were down slightly in midday trade on Friday. The stock has gained 8% year-to-date. The ecommerce giant is slated to report its earnings results
AbbVie Q1 2025 adjusted earnings increase on 8% revenue growth; beat estimates
Biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) announced first-quarter 2025 financial results, reporting an increase in revenue and adjusted earnings. The company reported worldwide net revenues of $13.3 billion for the
